Guangzhou Innogen Pharmaceutical Group Co., Ltd. - B - H Shs Stock: price and insider trades · Hong Kong
1 insider bought €1,024 of shares over the last 90 days, the latest by HUANG BING, filed 14 Sept 2026.
Guangzhou Innogen Pharmaceutical Group Co., Ltd. - B - H Shs: what insiders have been doing
Guangzhou Innogen Pharmaceutical Group Co., Ltd. - B - H Shs has a thin disclosure history in our data (latest filing: 14 September 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -13.8%Entry HK$4.08 · Close 21 Oct 2026 HK$3.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,400 shares@ HK$3.89100.0% of flowShareXHKGHKEX:DA20260914E00084Canonical exit: 10 Dec 2026 (T+90)
1 of 1 declaration
About Guangzhou Innogen Pharmaceutical Group Co., Ltd. - B - H Shs
Guangzhou Innogen Pharmaceutical Group Co., Ltd. is a company engaged in the development and manufacturing of pharmaceutical products. It focuses on innovation in the healthcare sector.
